Get started
Author

Peter John

Observed name: Peter A. John
OpenAlex ID: A5028197483
The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial
2019 · Peter John, Yao Wei, et al. · Trends in Pharmacological Sciences · 71
The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy
2022 · Peter John, Marc C. Pulanco, et al. · Nature Communications · 43
PDF
A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression
2023 · Yu Liu, Peter John, et al. · Developmental Cell · 30
PDF
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer
2022 · Titto Augustine, Peter John, et al. · Frontiers in Oncology · 15
PDF
The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1
2017 · Alexander Sankin, Deepa Narasimhulu, et al. · Urologic Oncology Seminars and Original Investigations · 10
Abstract 3917: Potentiating effect of reovirus in anti-PD1 therapy in colorectal cancer
2018 · Titto A. Augustine, Radhashree Maitra, et al. · Cancer Research · 4
Abstract 1606: Potentiating effect of olaparib on anti-PD-1 treatment in colorectal cancer
2021 · Chintal Bhavsar, Peter John, et al. · Cancer Research · 2
Abstract B009: A SOX9-B7x axis safeguards dedifferentiated tumor cells from immunosurveillance to enable DCIS progression
2022 · Yu Liu, Peter John, et al. · Cancer Prevention Research
Reovirus sensitizes microsatellite stable colorectal cancer to anti-PD-1 treatment via cross-talk in innate and adaptive immune systems
2021 · Titto Augustine, Peter John, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 1243: Effects of ITI-214, a potent and selective phosphodiesterase type 1 inhibitor, on tumor myeloid cellular composition, tumor volume and survival in mouse models of colorectal cancer when combined with an anti-PD-1 checkpoint inhibitor
2021 · Gretchen L. Snyder, Peter A. John, et al. · Cancer Research
Works count: 10
Citation count: 175
H-index: 5
I10-index: 5
Year
Topic
Type